Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIPS: Anakinra in Pediatric Sepsis-induced MODS
NCT05267821Phase 3Recruiting
- Sponsor
- Nationwide Children's Hospital
- Start
- Jun 2022
- Primary completion
- May 2028
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of anakinra in multiple organ dysfunction syndrome (MODS) (5 arms), sponsored by Nationwide Children's Hospital. Primary endpoint: Pediatric Logistic Organ Dysfunction 2 score at 28 days. Started Jun 2022; status: recruiting.
02
Drugs
anakinra
03
Conditions
multiple organ dysfunction syndrome (MODS)
Beyond the preview
Go deeper on NCT05267821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05267821.